Agios Pharmaceuticals | AGIO - Beneficio Operativo





Beneficio Operativo Cambio Fecha
AbbVie USD 6.72B 1.99B 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amgen USD 3.83B 130M 2026-03
Arrowhead Research USD -141.26M 182.07M 2026-03
Astellas Pharma JPY 48.57B 85.97B 2026-03
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 3.53B 2.42B 2026-03
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Daiichi Sankyo JPY 85.1B 4.44B 2026-06
Eli Lilly USD 9.78B 792M 2026-03
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Merck USD -1.88B 8.12B 2026-03
Moderna USD -815M 573M 2026-06
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.75B 515M 2026-06
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.99B 340M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03